Trial NCT04811573

View at ClinicalTrials.gov 
Org. Study IDs: 1407-0041
Secondary IDs: 2019-005037-37

Last trial update was posted on 2023-08-31

MeSH Interventions

Apremilast Thalidomide

MeSH Conditions


Other Conditions

Healthy

Stopping Reasons

due to company decision

Limitations And Caveats

This trial was prematurely discontinued due to sponsor decision. The planned recruitment amount was not reached. The planned statistical analyses of the pharmacokinetic parameters were not performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID